CHIME AJIERE: Open Payments
NPI 1851889018 · FRANKFORT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 57 payments from 16 companies in 2025. Trend: 2023 $2,978 · 2024 $2,399 · 2025 $1,360
Food & beverage: $1,348Education: $12
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $312 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $162 |
| ABBVIE INC. | 4 | $113 |
| Supernus Pharmaceuticals, Inc. | 3 | $105 |
| Janssen Pharmaceuticals, Inc | 4 | $103 |
| Alkermes, Inc. | 4 | $94 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Teva Pharmaceuticals USA, Inc. | 3 | $74 |
| Neurocrine BioSciences, Inc. | 2 | $64 |
| Braeburn Inc. | 2 | $58 |
Products named: CAPLYTA, REXULTI, VRAYLAR, Qelbree, ABILIFY ASIMTUFII, Auvelity, ARISTADA, INGREZZA.
Industry payments across IL — which companies pay providers there.
